All peptides
GH Releasing HormonesModerate evidence#2 in GHRHSubcutaneous · Into fat, under the skin

CJC-1295 (with DAC)

Also known as CJC-1295, DAC:GRF

CJC-1295 with DAC is a modified growth hormone releasing hormone (GHRH) analog engineered with a Drug Affinity Complex that binds circulating albumin, dramatically extending its activity compared to unmodified GHRH. Early clinical research reported sustained elevations in growth hormone and IGF-1 over days to weeks following a single dose. It is widely used in research and community protocols as a long-acting alternative to shorter-acting GHRH analogs, often paired with a GHRP for a stronger combined effect. Its long clearance time means effects, and any side effects, can persist well after the last dose.

Reported benefits

  • Sustained GH/IGF-1 elevation
  • Improved recovery and sleep quality
  • Supports lean mass over time
  • Convenient low-frequency dosing

How it works

The Drug Affinity Complex (DAC) covalently binds circulating albumin, protecting the attached GHRH(1-29) analog from rapid enzymatic degradation and greatly extending its half-life. This produces continuous, low-level stimulation of pituitary GHRH receptors, leading to a sustained rise in GH and IGF-1 rather than the discrete pulses seen with short-acting GHRH analogs.

Dosing ranges

TierDoseFrequency
Low1,000 mcgonce weekly
Moderate2,000 mcgonce weekly
High2,000 mcgtwice weekly

Estimate your dose

Dose estimator

Educational estimate for CJC-1295 (with DAC), scaled to body size. Not medical advice.

Read before using

This tool produces a rough, educational estimate by scaling commonly-published research ranges to lean body mass. It is not a prescription, medical advice, or a substitute for a licensed clinician. Most peptides use fixed dosing, not weight-based dosing. Individual needs vary. You are solely responsible for how you use this information.

Mixing & syringe units

Target dose follows the estimate above. Change it there, or edit it directly below.

Reconstitution calculator

How much water to add and how many insulin-syringe units to draw for CJC-1295 (with DAC). Educational only.

mL

Draw to this mark

40units

= 0.4 mL for a 2,000 mcg dose

0100 u (1 mL)

Concentration

5,000 mcg/mL

Doses per vial

5

A U-100 syringe reads 100 units per mL. This is a reconstitution math helper only, not a prescription or dosing advice. Verify every calculation and consult a qualified healthcare provider.

Possible side effects

Water retentionInjection-site irritationMild flushing or numbness after dosingPossible joint discomfortFatigue at high doses

Stacking notes

Commonly paired with a GHRP (such as Ipamorelin or GHRP-2) dosed separately to add pulsatile amplification on top of its sustained baseline elevation.

Common protocols

CJC-1295 DAC + IpamorelinCJC-1295 DAC + GHRP-2

Common questions

What is CJC-1295 (with DAC) used for?

CJC-1295 with DAC is a modified growth hormone releasing hormone (GHRH) analog engineered with a Drug Affinity Complex that binds circulating albumin, dramatically extending its activity compared to unmodified GHRH. Early clinical research reported sustained elevations in growth hormone and IGF-1 over days to weeks following a single dose. It is widely used in research and community protocols as a long-acting alternative to shorter-acting GHRH analogs, often paired with a GHRP for a stronger combined effect. Its long clearance time means effects, and any side effects, can persist well after the last dose. Reported benefits include sustained gh/igf-1 elevation, improved recovery and sleep quality, supports lean mass over time.

What is a typical CJC-1295 (with DAC) dose?

Reported ranges run 1,000-2,000 mcg. A low protocol is 1,000 mcg once weekly, and a high protocol is 2,000 mcg twice weekly. This is reference information, not a dosing recommendation.

What is the half life of CJC-1295 (with DAC)?

~8 days. That is what sets the dosing frequency, and it is why the timing guidance is ~30 min before bed, empty stomach.

How is CJC-1295 (with DAC) administered?

Subcutaneous: into fat, under the skin. Injected subcutaneously; long half-life allows once- or twice-weekly dosing

How long is a CJC-1295 (with DAC) cycle?

12-16 weeks on, followed by 4-8 weeks off. Long clearance means effects persist for weeks after stopping, so off-periods are extended accordingly

What are the side effects of CJC-1295 (with DAC)?

Reported side effects include water retention, injection-site irritation, mild flushing or numbness after dosing, possible joint discomfort, fatigue at high doses. Evidence level for this compound is moderate evidence.

Partner offer · $20 off

When did you last
check your blood work?

Regular blood work catches changes early. At-home collection with free pickup, 50+ biomarkers, and results in 72 hours.

  1. 1Order your kitTakes two minutes online, $20 off with this link.
  2. 2Collect at homePainless draw with free home pickup, no lab visit.
  3. 3Results in 72 hours50+ biomarkers with clear optimal ranges.
Get my blood test — $20 off

Partner offer · opens rythm.health

Educational use only, not medical advice. This profile is provided for research and educational purposes. CJC-1295 (with DAC) may be a research compound or a prescription medication; nothing here is intended to diagnose, treat, cure, or prevent any disease. Dosing figures reflect commonly-published research ranges, not a prescription. Consult a qualified healthcare provider before making any health decision. Read the full disclaimer →

Laboratory research use only

All compounds and information on this site are intended strictly for laboratory research and educational use only. They are not for human or veterinary use.

The statements on this website have not been evaluated by the U.S. Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure, or prevent any disease.

Educational use only. The information and calculators on this site are provided for research and educational purposes and are not medical advice, a diagnosis, a prescription, or a substitute for a licensed healthcare provider. Many compounds described are research compounds or prescription medicines not approved for general use. You must be 21 or older. Always consult a qualified clinician before making any health decision. Read the full disclaimer · Privacy Policy

© 2026 LifeConverted. All rights reserved.

Not for human or veterinary use.

Powered with by Plondo